Kytopen Revenue and Competitors
Estimated Revenue & Valuation
- Kytopen's estimated annual revenue is currently $10.8M per year.
- Kytopen's estimated revenue per employee is $155,000
Employee Data
- Kytopen has 70 Employees.
- Kytopen grew their employee count by 35% last year.
Kytopen's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder | Reveal Email/Phone |
2 | Co-Founder | Reveal Email/Phone |
3 | Co-Founder & Advisor | Reveal Email/Phone |
4 | CEO | Reveal Email/Phone |
5 | CTO | Reveal Email/Phone |
6 | Chief Commercial Officer | Reveal Email/Phone |
7 | VP Business Development | Reveal Email/Phone |
8 | VP Research & Development | Reveal Email/Phone |
9 | Associate Director, Research | Reveal Email/Phone |
10 | Director Technology Innovation | Reveal Email/Phone |
Kytopen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Kytopen?
Kytopen is an MIT startup developing their proprietary Flowfect technology for non-viral delivery of molecules into hard-to-transfect immune cells. The scalable Flowfect technology combines microfluidics and automation to make this process easier, faster, and cheaper than ever before. With our automated cell engineering platform we plan to enable new discoveries in biology that will lead to cost effective cell and gene therapies.
keywords:N/AN/A
Total Funding
70
Number of Employees
$10.8M
Revenue (est)
35%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $17M | 70 | -17% | N/A |
#2 | $8.2M | 70 | -25% | N/A |
#3 | $11.3M | 70 | 46% | N/A |
#4 | $17M | 70 | 4% | N/A |
#5 | $17M | 70 | 6% | N/A |